EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Human African trypanosomiasis (sleeping sickness)



Human African trypanosomiasis (sleeping sickness)



Releve Epidemiologique Hebdomadaire 74(30): 245-246



The WHO control programme for human African trypanosomiasis (caused by Trypanosoma gambiense and T. rhodesiense) is briefly described.

(PDF emailed within 1 workday: $29.90)

Accession: 003162715

Download citation: RISBibTeXText

PMID: 10446530



Related references

Sleeping hearts: the role of the heart in sleeping sickness (human African trypanosomiasis). Tropical Medicine & International Health 12(12): 1422-1432, 2007

Sleeping glands? - The role of endocrine disorders in sleeping sickness (T.b. gambiense Human African Trypanosomiasis). Acta Tropica 104(1): 16-24, 2007

Sleeping sickness - human African trypanosomiasis. Practical Neurology 5(5): 260-267, 2005

Human African trypanosomiasis (sleeping sickness). Handbook of clinical neurology Vol 35 Infections of the nervous system Part III: 67-83, 1978

FDG PET/CT in a Case of Human African Trypanosomiasis (Sleeping Sickness). Clinical Nuclear Medicine, 2018

Progress in human African trypanosomiasis, sleeping sickness. Progress in human African trypanosomiasis, sleeping sickness: xiii + 344 pp., 1999

Drug used in the treatment of sleeping sickness (human African trypanosomiasis: HAT). International Journal of Antimicrobial Agents 4(3): 227-238, 1994

Human African trypanosomiasis (sleeping sickness): epidemiological update. Releve Epidemiologique Hebdomadaire 81(8): 71-80, 2006

The continuing problem of human African trypanosomiasis (sleeping sickness). Annals of Neurology 64(2): 116-126, 2008

Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness). Lancet. Neurology 12(2): 186-194, 2013

Special issue. Human African trypanosomiasis: approaches to roll back sleeping sickness. Tropical Medicine and International Health 6(5): 327-420, 2001

Human African trypanosomiasis (sleeping sickness): new endemic foci in Bendel State, Nigeria. Tropical Medicine and Parasitology 40(1): 16-20, 1989

Role of molecular biology in the identification of trypanosomes responsible for human African trypanosomiasis or sleeping sickness. Medecine Tropicale 60(2): 115-119, 2000

Challenges towards the elimination of Human African Trypanosomiasis in the sleeping sickness focus of Campo in southern Cameroon. Parasites & Vectors 7: 374-374, 2015

Human trypanosomiasis and tsetse-flies in Liberia, III The treatment of African sleeping sickness with two new trivalent arsenical preparations. 1946